Navigation Links
UW launches study testing adult stem cells for heart damage repair

The University of Wisconsin School of Medicine and Public Health is among the first medical centers in the country taking part in a novel clinical trial investigating if a subject's own stem cells can treat a form of severe coronary artery disease.

The trial, just underway at UW Hospital and Clinics, is enrolling subjects in the Autologous Cellular Therapy CD34-Chronic Myocardial Ischemia (ACT34-CMI) Trial. The first patient underwent the procedure March 7. Because the study is randomized and "double-blinded," however, neither the patient nor the research physician knows if he received his own stem cells or a placebo substance.

This trial is the first human Phase II adult stem cell therapy study in the U.S. Its goal is to investigate the efficacy, tolerability, and safety of blood-derived selected stem cells to improve symptoms and clinical outcomes in patients with chronic myocardial ischemia (CMI), a severe form of coronary artery disease.

Myocardial ischemia, which affects hundreds of thousands of people, is a serious heart condition that involves narrowing of coronary arteries and results in limited blood flow to the heart. A person who suffers from chronic myocardial ischemia continues to experience insufficient flow of oxygen-rich blood to the heart despite optimum medical intervention.

This type of therapy - regenerative medicine - treats diseases by using growth factors, genes or stem cells to promote blood vessel or tissue growth," explains Amish Raval, head of cardiovascular regenerative medicine at UW Health.

The goal with this approach, he says, is to promote either angiogenesis, which is the growth of new capillaries; arteriogenesis, or the maturation and enlargement of existing arteries and arterioles; or vasculogenesis, the sprouting of new arteries and arterioles.

The stem-cell study is considered the "gold standard" of research design: a prospective, randomized, double-blind, placebo-controlled
'"/>

Source:University of Wisconsin-Madison


Page: 1 2 3

Related biology news :

1. UCLA launches $20 million stem cell institute to investigate HIV, cancer and neurological disorders
2. UNC launches study of liver injury caused by drugs
3. DOE JGI launches IMG public online microbial genome data clearinghouse
4. NIEHS launches website with information for assessing environmental hazards from Hurricane Katrina
5. NIH launches comprehensive effort to explore cancer genomics
6. Virginia Bioinformatics Institutes launches microbial database
7. BioMed Central launches Biology Direct
8. Protein structure initiative launches new resources for the scientific community
9. NIH neuroscience microarray consortium launches high-throughput genotyping services
10. ESA launches new project to protect biodiversity
11. Africas first large-scale HIV vaccine study launches
Post Your Comments:
(Date:7/24/2008)...ded with a telescope promise to make it easier for... activities requiring sharper distance vision. Sch...he advantages of these innovative glasses over ear...ne issue of Journal of Biomedical Optics , mailed...his new design has several advantages," says the i...
(Date:7/24/2008)... A new study by researchers from Columbia Univers...e of the most challenging issues in infant health ... poor countries. In these settings, HIV-infected ... for their infants, they should exclusively breast...ths after birth. But according to the study conduc...
(Date:7/24/2008)...t The Pennsylvania State University College of Med...the efficacy of imiquimod, a clinically important ... antitumor activity, is dependent on the Opioid Gr... action. This discovery, reported in the August 0...ovides new insights into a widely used drug that m...
(Date:7/24/2008)...ss. -- Scientists at Harvard University and the Un...c evolution is strongly shaped by genes, efforts t.... , Their study also suggests that the cost of e...ed proteins themselves, rather than the loss of fu... in long-lived cells, like neurons, and cause neur...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3Window of opportunity for restoring oaks small new study finds 3313 1Despite Americans High Regard Nursing Shortage Still Looms 19356 1Despite Americans High Regard Nursing Shortage Still Looms 19356 2Takeda Completes Acquisition of Millennium 19352 1Takeda Completes Acquisition of Millennium 19352 2Takeda Completes Acquisition of Millennium 19352 3Spherix Holds Annual Shareholders Meeting 5398 1Spherix Holds Annual Shareholders Meeting 5398 2
...maging research at the University of North Carolin...utism look at a face, activity in the brain area t...autism. , The finding is surprising, as it is wide...ooking directly at faces. The research also counte...sing area at the back of the brain is under-respon...
...n University researchers have developed a novel, t...bserve how interacting with the microenvironment o...lls to become similar to aggressive cancer cells t... model, developed by Mary J. C. Hendrix and collea...sts of a three-dimensional collagen matrix precond...
...h by scientists at UCSF sheds light on how the odo...ct their social behavior. , "Understanding how mi...egulates the sense of smell--should provide insigh...rains use to transform sensory information into be...D, UCSF assistant professor of anatomy. , "There ...
...sticated detection methods, researchers at the Sai...gy (IMV) have demonstrated the molecular mechanism...althy cells. The discovery could lead to new drug ...d that two ends of the virus, DNA must come togeth...til now, investigators have not been able to illum...
Other Biology News:Brain activity related to processing faces is similar in people with, without autism 2Brain activity related to processing faces is similar in people with, without autism 3Model identifies genes that induce normal skin cells to become abnormal 2New study examines how sense of smell affects mating and aggression in mice 2SLU researchers uncover direct evidence on how HIV invades healthy cells 2
(Date:7/25/2008)... -- BioTrends Research Group, Inc.,released its 10...ation, a,syndicated report offering comprehensive ...ne and mineral metabolism in Chronic Kidney Diseas...ion from 182 US,Nephrologists -- data were collect... In the renal anemia market, while the use of ESA...
(Date:7/25/2008)...RY, July 25 / Resverlogix C... pleased to announce effective,immediately Jan Gra... On,the subject of her appointment Jan Gray said, ...pportunity for me. The Company has done a wonderfu...rials. I expect the next,foreseeable future to be ...
(Date:7/25/2008)...stCall/ -- Caraco Pharmaceutical,Laboratories, Ltd...rter of,Fiscal 2009, ended June 30, 2008, of $108....rresponding period of Fiscal 2008. This represents...cal 2008. Pre-tax income grew,to $14.6 million for...,pre-tax income of $9.6 million during the corresp...
(Date:7/25/2008)...swire/ -- REvolution Computing will,lead a hands-o... at the,upcoming BioC 2008 conference in Seattle. ...on Computing Director of Community, Dr. David Hend... Manager, and Martin Morgan of,the Fred Hutchinson...oC lab,will introduce participants to the parallel...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
... and power solutions giant Johnson Controls, Inc....itions reflecting the creation an Executive Operat...xecutive vice president, was named chairman of the...employee of Johnson Controls since 1982, Roell ser...from 1991 to 2004. He was named executive vice pre...
...lvania teaching and research hospital are integrat... instruction to distribute information about diabe...cs. , ,The Penn State Milton S. Hershey Medical C...ions tool to record and transmit presentations, le... to medical students and other audiences over the ...
...ne is a concept that appears a long way from becom...led genetic-based medicine is closer than we think...rofiles will be used to identify the patient,s pre...sease management programs tailored to individual g...ephens Cracking the human genome has made persona...
... natural and man-made disasters, a Wisconsin truck...olstered business network. , ,The purchase will ou...histicated networking solutions, including a singl... over five years. , ,The solutions, provided by A...cations companies, are intended to help preserve "...
Other Biology Technology:Medical College researcher working to make genetic-based medicine a reality 2Medical College researcher working to make genetic-based medicine a reality 3
Polyclonal Antibody to CLAN
Request Info
IRF7 Immunogen: Synthetic peptide corresponding to residues E(463) G T Q R E G V S S L D S S S(477) of human IRF7. Storage: -20 C, Avoid Freeze/Thaw Cycles
Rabbit polyclonal to TetR ( Abpromise for all tested applications). Antigen: Synthetic peptide: AQKLGVEQPTLYWHVKNKR, corresponding to amino acids 31 - 49 of TetR
Biology Products: